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Abstract
Introduction We assessed outcome and outcome-measure reporting in randomised controlled trials evaluating surgical interven-
tions for anterior-compartment vaginal prolapse and explored the relationships between outcome reporting quality with journal
impact factor, year of publication, and methodological quality.
Methods We searched the bibliographical databases from inception to October 2017. Two researchers independently selected
studies and assessed study characteristics, methodological quality (Jadad criteria; range 1–5), and outcome reporting quality
Management of Otitis Media with Effusion in Cleft Palate (MOMENT) criteria; range 1–6], and extracted relevant data. We used
a multivariate linear regression to assess associations between outcome reporting quality and other variables.
Results Eighty publications reporting data from 10,924 participants were included. Seventeen different surgical interventions
were evaluated. One hundred different outcomes and 112 outcome measures were reported. Outcomes were inconsistently
reported across trials; for example, 43 trials reported anatomical treatment success rates (12 outcome measures), 25 trials reported
quality of life (15 outcome measures) and eight trials reported postoperative pain (seven outcome measures). Multivariate linear
regression demonstrated a relationship between outcome reporting quality with methodological quality (β = 0.412; P = 0.018).
No relationship was demonstrated between outcome reporting quality with impact factor (β = 0.078; P = 0.306), year of publi-
cation (β = 0.149; P = 0.295), study size (β = 0.008; P = 0.961) and commercial funding (β = −0.013; P = 0.918).
Conclusions Anterior-compartment vaginal prolapse trials report many different outcomes and outcomemeasures and often neglect to
report important safety outcomes. Developing, disseminating and implementing a core outcome set will help address these issues.
Keywords Anterior repair . Colporrhaphy . Core outcome sets . Cystocele . Outcomes . Outcomemeasures
Introduction
The most common type of pelvic organ prolapse (PO) is
anterior-compartment prolapse. Hendrix et al. demonstrated
in a group of 16,616 postmenopausal women a prevalence
of anterior-compartment prolapse of 34%, and this was much
higher than the rates of apical- or posterior-compartment pro-
lapse [1]. The aetiology of pelvic organ prolapse (POP) is
complex and associated with various factors such as age, men-
opausal status and childbirth-related pelvic floor trauma [2, 3].
Possible surgical interventions include biological-graft, mesh
and native tissue repair [4, 5]. The development of new surgi-
cal interventions is urgently required, and potential surgical
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interventions require robust evaluation. Selecting appropriate
efficacy and safety outcomes is a crucial step in designing
randomised trials. Outcomes collected and reported in
randomised trials should be relevant to a broad range of stake-
holders, including women with anterior-compartment pro-
lapse, healthcare professionals and researchers. For example,
resolution of bladder symptoms is an important outcome for
all stakeholders; however, it is not commonly reported across
trials. Even when outcomes have been consistently reported,
secondary research methods, including pair-wise meta-analy-
sis, may be limited by the use of different definitions and
measurement instruments [6, 7]. A core outcome set should
help address these issues. The first stage in core outcome-set
development is to evaluate outcome and outcome-measure
reporting across published trials. Therefore, we systematically
evaluated outcome and outcome-measure reporting in pub-
lished randomised trials evaluating surgical interventions for
anterior-compartment prolapse. In addition, we assessed the
relationships between outcome reporting quality with other
important variables, including year of publication, impact fac-
tor and methodological quality.
Materials and methods
This systematic review is part of a wider project of the
International Collaboration for Harmonising Outcomes,
Research and Standards in Urogynaecology and Women’s
Health (CHORUS) (i-chorus.org) and was registered with the
Core Outcome Measures in Effectiveness Trials (COMET) ini-
tiative database, registration number 981, and with the
International Prospective Register of Systematic Reviews
(PROSPERO), registration identification CRD42017062456.
We searched bibliographical databases comprising the
Cochrane Central Register of Controlled Trials (CENTRAL),
EMBASE and MEDLINE from inception to September 2017.
The search strategy used several MeSH terms, including bladder
prolapse, cystocele and POP. Randomised trials evaluating sur-
gical interventions for anterior-compartment prolapse were eligi-
ble. We included trials evaluating the surgical management of
anterior prolapse as a unicompartmental prolapse procedure, as
well as trials in which anterior repair was undertaken in addition
to other surgical interventions. Non-randomised studies, obser-
vational studies and case reports were excluded.
Two researchers (CD and AE) independently screened the
titles and abstracts of electronically retrieved articles. The ar-
ticles potentially eligible for inclusion were retrieved in full
text to assess eligibility, and reference lists were independently
reviewed. Any discrepancies between the researchers were
resolved by review of a third senior researcher (SKD). Two
researchers (CD and AE) independently extracted the study
characteristics, including year of publication, journal topical-
ity (subspecialist, general obstetrics and gynaecology or gen-
eral medicine), journal’s impact factor and commercial
funding (yes/no). The journal’s impact factor was determined
using InCites Journal Citation Reports (Clarivate Analytics,
Thomson Reuters, New York, NY, USA). Funding status was
identified by reviewing the article text and included the
Fig. 1 Study search and inclusion
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donation of equipment or other resources. Two researchers
(CD and AE) independently assessed the methodological
quality of included randomised trials using the modified
Jadad criteria (score range 1–5) [8]. Studies were assessed as
high quality when they achieved a score >4. Outcome
reporting quality was assessed using the Management of
OtitisMedia with Effusion in Cleft Palate (MOMENT) criteria
(score range 1–5) [9]. Studies were assessed as high quality
when they achieved a score >4.
The non-parametric Spearman’s rank correlation coeffi-
cient (Spearman’s rho) was used to explore univariate associ-
ations between outcome reporting quality and impact factor
during the year of publication, year of publication and meth-
odological quality. Multivariate linear regression analysis
using the Enter model was also undertaken to assess the com-
bined association of quality of outcome reporting and journal
type, impact factor during the year of publication, year of
publication and methodological quality (independent vari-
ables) with outcome reporting (dependent variable). All tests
were two-tailed. Statistical significance was set at 0.05, and
analyses were conducted using the SPSS statistical software
(IBM Corp. Released 2013. IBM SPSS Statistics for
Windows, Version 22.0. Armonk, NY, USA).
This study was reported with reference to the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) statement [6].
Results
In total, 2482 titles and abstracts were screened, and 231
potentially relevant studies were examined in detail
(Fig. 1). Sixty-eight randomised trials, reporting data from
10,499 participants, met the inclusion criteria (Table 1) [5,
10–88]. Additionally, 12 randomised trials published long-
term follow-up data [5, 22, 29, 39, 40, 64, 71, 72, 79, 81,
86, 87].
Trials were published between 1985 and 2017, with most
being published in subspecialty journals (33/80; 41%). Trials
were frequently published in journals with an impact factor <3
[median = 2.7; interquartile range (IQR) = 2.2–4.3] and were
generally small (median = 93; IQR = 60–154). Ten trials
(14%) declared commercial funding. The methodological
quality and outcome reporting quality varied considerably be-
tween trials (Table 1). One hundred different outcomes were
organised into 11 thematic domains. The three most common-
ly reported thematic domains were presence of symptoms
posttreatment (50 trials, 28 outcomes; 28 outcome measures),
prolapse treatment success rates (47 trials; 3 outcomes; 16
outcomemeasures) and perioperative complications (46 trials;
15 outcomes; 13 outcome measures) (Table 2). Commonly
reported outcomes were anatomical prolapse stage (43 trials;
54%), commonly assessed using the Pelvic Organ Prolapse
Quantification (POP-Q) instrument (35 trials; 81%), QoL
(25 trials; 31%); and intra- and postoperative complications
(23 trials; 29%). Patient-reported outcomes were infrequently
reported; for example, a minority of trials reported prolapse
symptoms (9 trials; 11%), urinary symptoms (11 trials; 14%)
and sexual dysfunction (14 trials; 17%) (Table 3). Eleven trials
(14%) reported patient satisfaction.
Forty-two randomised trials compared native tissue or
biological graft versus mesh repair for anterior vaginal pro-
lapse. Mesh-related complications were rarely reported:
seven trials (9%) reported mesh erosion, six (7%) reported
mesh shrinkage and a single trial (1%) reported the degree
of morbidity associated with mess Only three trials (4%)
evaluated cost effectiveness. One hundred and twelve dif-
ferent outcome measures wer reported (Table 4). Forty-six
questionnaires were used as measurement instruments,
most of which were validated (45; 98%). Anterior prolapse
symptoms were measured using the Pelvic Organ Prolapse
Urinary Incontinence Sexual Questionnaire (PISQ-12) (13
trials; 16%), Urogenital Distress Inventory (UDI-6) (11
trials; 14%) and the Pelvic Floor Distress Inventory
Table 2 Most commonly






Presence of symptoms posttreatment 50 28 28




Quality of life and satisfaction
with treatment
40 5 25
Treatment success evaluation 15 11 –
Postoperative catheterisation 10 17 10
Pain 9 4 7
Mesh-related outcomes 8 3 –
RCT randomised controlled trial
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Table 3 Outcomes reported in 80 randomised controlled trials (RCTs)
evaluating surgical management of anterior-compartment prolapse
Outcomes Reporting
studies
Prolapse treatment success rate
Anatomical prolapse stage 43
Composite anatomical/functional success rate 3
Urethral mobility 1
Perioperative complications and observations
Complications intra-/postoperatively 23
Postoperative hospital stay length 11
Blood loss intraoperatively 6
Duration of operation 6
Quality and time of recovery 4
Postoperative nausea and vomiting 3
Bleeding postoperatively (with/out vaginal pack use) 2
Constipation preoperatively 2
Blood pressure 2
Blood transfusion indicated 2
Heart rate change 2
Consistency of bowel movement postoperatively 1
Intra- and postoperative morbidity 1
Time to first postoperative bowel movement 1
Time to mobilisation 1
Pain
Postoperative pain 8
Intraoperative requirement of analgesics 1
Total analgesic consumption 1






Postoperative catheterisation duration 4
First postvoid residual volume 4
Time to normal spontaneous voiding 2
Acute urinary retention 1
Bacterial count in the urine 1
Catheter blockage 1
Day of spontaneous voiding 1
Diagnostic accuracy of different voiding trial methods 1
Mean residual urine volume pre- and postoperatively 1
Prediction of voiding dysfunction lasting >7 days. 1
Prolonged catheterisation 1
Pyelectasia 1
Residual urine volume 1
Urinary retention prevention with intravesically
administered prostaglandin-E2
1
Urinary retention rates 1
Postoperative vaginal packing
Bleeding postoperatively (with/out vaginal pack use)





Bleeding postoperatively (with/out vaginal pack use) 1
Presence of vaginal haematoma 1
Presence of vaginal infection 1
Bother related to the pack 1
Presence of symptoms posttreatment
Sexual dysfunction symptoms 14
Urinary symptoms 11
Prolapse symptoms postoperatively 9
Dyspareunia 6
SUI postoperatively 5
De novo SUI postoperatively 4
Change in urinary symptoms (any) 3
Prolapse symptoms severity 3
De novo urinary urgency 2
Postoperative urinary symptoms 2
Urinary symptoms severity 2
Bowel symptoms 2
Faecal incontinence 2
Postoperative bowel symptoms 2
Change in incontinence rates 1
De novo urinary symptoms 1
De novo voiding difficulty 1
Urgency and urge urinary incontinence 1
Worsening urinary symptoms (any) 1
Obstructed defecation 1
Back pain improvement 1
Change in a pelvic symptom score 1
Change of vaginal symptoms 1
Symptomatic prolapse improvement 1
Time of prolapse recurrence 1
De novo dyspareunia 1
Sexual function in partner 1
QoL and satisfaction with treatment
QoL and impact from symptoms evaluation 25
Patient satisfaction with treatment 11
Surgeon satisfaction with operation 2
Patient acceptability of preoperative bowel preparation 1
Surgeon—ease of procedure 1
Treatment success evaluation
Symptoms—presence posttreatment 5
Subjective cure rates 3
Cure of SUI postoperatively 3
Reoperation rates 3
Symptoms—bother change 2
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(PFDI-20) (9 trials; 11%). QoL was measured using the
Prolapse Quality of Life (P-QoL) (10 trials; 12%), Pelvic
Floor Impact Questionnaire Short Form (PFIQ-7) (8 trials;
10%) and the Incontinence Impact Questionnaire Short
Form (IIQ-7) (6 trials; 7%). Table 5 summarises our main
findings, demonstrating the most frequently reported out-
comes. It reveals the significant discrepancies in terms of
outcome reporting.
We observed a moderate correlation between outcome
reporting quality and year of publication in the univariate
analysis (r 0.458; p < .001) and study quality (r 0.409; p
< .001) (Table 6). The latter index significantly affected out-
come reporting in the multivariate logistic regression (β =
0.412; p = .018).
Discussion
Summary of main findings
This study demonstrated considerable variation in outcome
and outcome-measure reporting across published trials
evaluating surgical interventions for anterior-compartment
prolapse. Commonly reported outcomes included normal-
ised anatomy, QoL and pain. Patient-reported outcomes
were infrequently reported, and a minority of trials reported
on patient satisfaction. Mesh-related complications, includ-
ing erosion, shrinkage and morbidity, were rarely reported.
Forty-five different questionnaires were used as measure-





Need for subsequent anti-incontinence surgery 1




Degree of morbidity in mesh vs. native tissue 1
Cost/effectiveness
Cost-effectiveness of treatment 2
Cost of procedure 1
Recruitment feasibility
Number of patients agreed to participate 1
Number of eligible patients 1
Physician acceptance and protocol 1
Rate of recruitment compliance 1
UTI urinary tract infection, SUI stress urinary incontinence, QoL quality
of life
Table 4 Outcome measures reported in 80 randomised controlled trials
(RCTs) evaluating surgical management of anterior-compartment
prolapse
Outcomes No of reporting
studies
Prolapse treatment success rate
Anatomical success rate POP-Q < 2 23
Anatomical success rate (POP-Q ≤ 1) 5
Anatomical success rate
(postoperative POP-Q stage improvement)
5
Anatomical success rate (POP above hymen) 3
Anatomical success rate POP-Q ≤ 2 2
Anatomical success rate (POP-Q < 2 vs. POP-Q ≤ 1) 1
Anatomical success rate POP-Q Index (POP-Q-I) = 0 1
Anatomical success rate
(postoperative POP-Q + BW stage improvement)
1
Anatomical success rate (cotton swab mobility test) 1
Composite success rate
(POP-Q < 2 + UDI question 16 negative
1
Composite success rate (POP above hymen +
VAS >20 (0–100 scale))
1
Composite success rate -
(POP above hymen + no symptoms)
1
Composite success rate -
(apex below levator plate + no symptoms)
1
Denovo POP in untreated compartments (POP-Q ≥ 2) 1
Denovo POP in untreated compartments
(POP ≥ hymen)
1
Recurrence rate of POP
(halfway BW stage change)
1
Perioperative complications and observations
Postoperative hospital stay length (days) 11
Blood loss (ml) 8
Duration of operation (min) 6
PONV (postoperative nausea and vomiting),
visual analogue scale [VAS (0–10)]
2
PONV scale 2
PONV QoR (quality of recovery) score > 50 2
Recovery time (days) 2
PONV intensity score [QoR (0–40)] 1
Blood pressure (mmHg) 1
Heart rate (beats/min) 1




(Rome III constipation questionnaire)
1




VAS (not specified) 2
Mcgill pain questionnaire 2
Verbal numerical pain scale (0–10) 1
Baudelocque’s questionnaire 1
Nonvalidated questionnaire (0–3) 1
Postoperative catheterisation
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Strengths and limitations
Strengths of our systematic review include originality, a rig-
orous search strategy and methodological robustness. To our
Table 4 (continued)
Outcomes No of reporting
studies
Postoperative catheterisation duration (days) 4
Day of spontaneous voiding (days) 3
Bacterial count in the urine 1
Residual urine volume (ml) 1
First PVR (postvoid residual volume) > 150 ml 1
First PVR > 1500 ml 1
Mean residual urine volume pre- and
postoperatively (ml)
1
Recatheterisation if PVR >200 ml 1
Prediction of voiding dysfunction >7 days
(positive predictive value)
1




Bleeding postoperatively (with/out vaginal pack use)
(compared with menstrual average)
1
Bleeding postoperatively (with/out vaginal pack use)
[FBC change and volume (ml)]
1
Blood pressure (mmHg) 1
Heart rate (beats/min) 1
Blood transfusion indicated (yes/no) 1
Vaginal haematoma (TVUSS) 1
Vaginal infection (HVS) 1
Bother related to the pack (VAS 0–100) 1
Presence of symptoms posttreatment
PISQ-12 (Pelvic Organ Prolapse Urinary
Incontinence–Sexual Questionnaire)
13
UDI-6 (Urogenital Distress Inventory) 11
PFDI-20 (Pelvic Floor Distress Inventory) 9
SUI urodynamic studies 7
DDI (Defecatory Distress Inventory) 5
ICIQ-UI SF (International Consultation on Incontinence
Questionnaire–Short Form)
4
SUI cough test (presence of leakage) 4
FSFI (Female Sexual Function Index) 2
ICIQ-BS (International Consultation on Incontinence
Questionnaire–Bowel Symptoms)
2
PGI-I (Patient Global Impression of Improvement) 2
OAB-V8 (Overactive Bladder-Validated 8-question) 2
POPDI-6 (Pelvic Organ Prolapse Distress Inventory) 2
POP-SS (Pelvic Organ Prolapse Severity of
Symptoms)
2
UDI-I (Urogenital Distress Inventory–Irritative) 2
UDI-O (Urogenital Distress Inventory-Obstructive) 2
UDI-S (Urogenital Distress Inventory–Stress) 2
AUASS [American Urological Association
Symptom Score (urinary)]
1
CRADI-8 (Colorectal–Anal Distress Inventory) 1
CRAIQ-7 (Colorectal–Anal Impact Questionnaire) 1
Danish prolapse questionnaire 1





Outcomes No of reporting
studies
MESAAQ (Medical Epidemiologic and Social Aspects
of Ageing Questionnaire)
MHU (French Urinary Dysfunction
Measurement Scale)
1
MSHQ (Male Sexual Health Questionnaire) 1
PGI-S (Patient Global Impression of Severity) 1
QS-F (Sexual Quotient–Female Version) 1
SUI number of daily pads 1
Impact on quality of life
P-QoL (Prolapse Quality of Life) 10
PFIQ-7 (Pelvic Floor Impact Questionnaire–
Short Form)
8
IIQ-7 (Incontinence Impact Questionnaire–Short Form) 6
ICIQ-UI SF (International Consultation on Incontinence
Questionnaire–Urinary Symptoms)
4
ICIQ-VS (International Consultation on Incontinence
Questionnaire–Vaginal Symptoms)
3
KHQ (King’s Health Questionnaire) 3
UIQ-7 (Urogenital Impact Questionnaire) 3
DDI (Defecatory Distress Inventory) 2
EQ5D [Quality of Life (EuroQol)] 2
POPIQ-7 (Pelvic Floor Impact Questionnaire–Prolapse) 2
VAS (0–10) 2
CRAIQ-7 (Colorectal–Anal Impact Questionnaire) 1
PSI-QOL (Prolapse Symptom Inventory and Quality
of Life Questionnaire)
1
SF-12 (12-Item Short-Form Health Survey) 1
SF-36 (36-Item Short-Form Health Survey) 1
Satisfaction
Patient satisfaction with treatment, VAS (0–10) 3
Patient satisfaction with treatment, PGI (Patient
Global Improvement)
3
Patient satisfaction with treatment (yes/no) 3
Patient satisfaction with treatment, VAS (0–100) 2
Patient satisfaction with treatment, VAS (0–4) 1
Patient satisfaction with treatment, custom (0–5) 1
Patient acceptability of preoperative bowel
preparation, VAS) (0–4)
1
Surgeon satisfaction with preoperative bowel
preparation, Likert scale (0–4)
1
Surgeon ease to perform operation, Likert scale (0–4) 1
Surgeon’s satisfaction with operation, VAS (0–100) 1
Cost/effectiveness
Incremental cost per quality-adjusted life-year (QALY) 2
Cost of procedure (US$) 1
TVUSS transvaginal ultrasound scan, HVS high vaginal swab, FBC full
blood count
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knowledge, this systematic review is the first to evaluate out-
comes and outcome measures in anterior-compartment pro-
lapse trials. Study screening and selection and data extraction
and assessment were conducted independently by two re-
searchers to avoid bias. Our findings were based on outcome
reporting in published randomised trials. The exclusion of
observational studies may have potentially missed outcomes
related to harm [89, 90] and selecting only trials reported in
English may have introduced selection bias. The variation of
interventions for correcting anterior prolapse may have caused
variation in outcome and outcome-measure reporting.
Interpretation
Randomised trials require a substantial investment of re-
sources. Variation in outcomes and outcome measures limits
the ability of trials to be combined with meta-analyses, which
contributes to inevitable research waste, as identified in vari-
ous areas of women’s health, including childbirth trauma, en-
dometriosis and pre-eclampsia [91–94]. This systematic re-
view is the first step in the development of a minimum data
set, which will be known as a core outcome set. It will be
developed with reference to methods described by the
COMET initiative, Core Outcomes in Women’s and
Newborn Health (CROWN) initiative and other core-
outcome-set development studies, including those on endo-
metriosis, pre-eclampsia, termination of pregnancy, Twin-
Twin Transfusion Syndrome and neonatal medicine [95–99].
CHORUS is aiming to work towards a standardisation of
outcomes and outcome measures and subsequently establish a
minimum of standards in research and clinical practice.
Chorus working groups are currently evaluating reported out-
comes in all areas of urogyneacology and have been registered
with the COMET (registration number 981, http://www.
comet-initiative.org/studies/details/981) and CROWN
initiatives. Each working group has carefully considered the

























































































































































































































Table 6 Univariate andmultivariate correlation with outcome reporting
quality
Factor Univariate Multivariate
Spearman’s rho P value Beta P value
Study quality (Jadad) 00.409 <0.001 0.412 0.018
Journal IF 0.053 0.643 0.078 0.306
Year of publication 0.458 <0.001 0.149 0.295
Study size 0.215 0.051 0.008 0.961
Journal type – – 0.024 0.852
Commercial funding – – −0.013 0.918
Validated questionnaire – – 1.310 0.196
Bolded data statistically significant
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success of other international initiatives that have standardised
outcome selection, collection and reporting across preterm
birth research [101].
In the absence of a core outcome, we recommend QoL
(incorporating sexual function), postoperative complications,
patient and physician satisfaction and postoperative prolapse,
bladder and bowel symptoms be collected across all anterior
prolapse trials.
Conclusion
Anterior-compartment prolapse trials report many different
outcomes and outcome measures and often neglect to report
important safety outcomes. Developing, disseminating and
implementing a core outcome set will help address these
issues.
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